Chemotherapy-induced peripheral neuropathy: a new treatment option

Your saved search

Your RSS Feed

Editorial

. 2012 Nov;29(7):509-11.

doi: 10.1177/1049909112458578.

Editorial

Robert E Enck. Am J Hosp Palliat Care. 2012 Nov.

. 2012 Nov;29(7):509-11.

doi: 10.1177/1049909112458578.

No abstract available

Similar articles

Chemotherapy-induced peripheral neuropathy.
Armstrong T, Almadrones L, Gilbert MR. Armstrong T, et al. Oncol Nurs Forum. 2005 Mar 5;32(2):305-11. doi: 10.1188/05.ONF.305-311. Oncol Nurs Forum. 2005. PMID: 15759068 Review.
Chemotherapy-induced peripheral neuropathy in pediatric cancer patients.
Gilchrist L. Gilchrist L. Semin Pediatr Neurol. 2012 Mar;19(1):9-17. doi: 10.1016/j.spen.2012.02.011. Semin Pediatr Neurol. 2012. PMID: 22641071 Review.
Peripheral neuropathy induced by oxaliplatin-based chemotherapy.
[No authors listed] [No authors listed] J Support Oncol. 2006 Feb;4(2):82-3. J Support Oncol. 2006. PMID: 16499128 No abstract available.
Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement.
Dunlap B, Paice JA. Dunlap B, et al. J Support Oncol. 2006 Sep;4(8):398-9. J Support Oncol. 2006. PMID: 17004514 No abstract available.
Reversal of dose-limiting carboplatin-induced peripheral neuropathy with TRPM8 activator, menthol, enables further effective chemotherapy delivery.
Storey DJ, Colvin LA, Mackean MJ, Mitchell R, Fleetwood-Walker SM, Fallon MT. Storey DJ, et al. J Pain Symptom Manage. 2010 Jun;39(6):e2-4. doi: 10.1016/j.jpainsymman.2010.02.004. J Pain Symptom Manage. 2010. PMID: 20538177 No abstract available.